Munich, Germany

Martin Mikyna

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martin Mikyna: Innovator in Pharmaceutical Device Technology

Introduction

Martin Mikyna is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceutical technology, particularly in the administration of medications. His innovative approach has led to the development of a unique device that enhances drug delivery methods.

Latest Patents

Martin Mikyna holds a patent for a "Pharmaceutical device for electric-field assisted administration of Tapentadol and method of administering Tapentadol with same." This device is designed to facilitate the electric-field assisted administration of Tapentadol and/or its physiologically acceptable salts. The device comprises at least one pair of electrodes, including an active electrode and a counter electrode, along with a drug reservoir containing Tapentadol. It also features means for applying the device to the skin, showcasing a novel approach to medication delivery.

Career Highlights

Throughout his career, Martin has been associated with Gruenenthal GmbH, a company known for its focus on innovative pharmaceutical solutions. His work has contributed to advancements in drug administration techniques, particularly in pain management.

Collaborations

Martin has collaborated with several professionals in his field, including Ingo Friedrich and Sandra Gedat. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Martin Mikyna's contributions to pharmaceutical device technology exemplify the impact of innovation in healthcare. His patented device represents a significant advancement in the administration of medications, particularly in enhancing the efficacy of Tapentadol delivery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…